Genetic Biomarkers for Statin-Induced Myopathy. [PDF]
Prieto-Peña D +10 more
europepmc +1 more source
Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes. [PDF]
Şahin MF, Erol A, Bayrak G, Şahin A.
europepmc +1 more source
Trends in Lipid-Lowering Agent Consumption in Croatia: A 25-Year Observational Study. [PDF]
Belančić A +5 more
europepmc +1 more source
Evaluating Bioassays for the Determination of Simvastatin's Osteogenic Activity: A Systematic Review. [PDF]
Back LS +7 more
europepmc +1 more source
Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait [PDF]
Danish Iqbal +5 more
core +1 more source
HMG-CoA reductase inhibition preserves testicular function after torsion/detorsion by modulating oxidative stress and AKT signaling. [PDF]
Yıldırım B +8 more
europepmc +1 more source
Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent [PDF]
Acimovic J +11 more
core +1 more source
Activity-based probes and chemical proteomics uncover the biological impact of targeting HMG-CoA Synthase 1 in the mevalonate pathway. [PDF]
Yi SA +5 more
europepmc +1 more source

